Ceftolozane-tazobactam
Cost effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections
... A few limitations to the study deserve mention. Firstly, the PACTS dataset does not contain enough information to specifically target (a) cUTI patients and (b) all patients in the PACTS dataset at risk for resistant ...
10
Profile of ceftolozane/tazobactam and its potential in the treatment of complicated intra-abdominal infections
... of ceftolozane/tazobactam, has a similar inhibitor, relebactam in combination with ...come: ceftolozane/ DBO inhibitor, perhaps combined with aztreonam to combat metallo- β -lactamase producing ...
7
Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infections
... prospective, randomized, double-blind, active comparator trials were conducted across 136 centers in 30 countries. The study was designed as a noninferiority trial with a - 12.5% margin, lower than the - 10% margin ...
16
Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination
... clinicians. Ceftolozane/tazobactam is a novel antibacterial and β-lactamase-inhibitor combination that has shown appreciable activity against wild-type Enterobacteriaceae and potent activity against ...
9
Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen distributions drawn from national surveillance data in the United States
... of ceftolozane/tazobactam + metronidazole compared with piperacillin/tazobactam in the treatment of hospitalized US patients with cIAI at risk of infection with resistant ...either ...
10
Analysis of patients with diabetes and complicated intra abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam
... this, ceftolozane/tazobactam was as effective as com- parators in treating cUTI and cIAI in patients with diabetes—a population at increased risk for infections and poor clinical ...
8
Multicenter Evaluation of the Etest Gradient Diffusion Method for Ceftolozane Tazobactam Susceptibility Testing of Enterobacteriaceae and Pseudomonas aeruginosa
... ABSTRACT Ceftolozane-tazobactam (C/T) is a novel beta-lactam– beta-lactamase inhibi- tor combination antibiotic approved by the U.S. Food and Drug Administration in 2014 for the treatment of complicated ...
8
<p>Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy</p>
... priority. Ceftolozane – tazobactam (C/T) is a new combination of a cephalosporin with a β -lactamase inhibitor that shows excellent in vitro activity against a broad spectrum of Enterobacteriaceae and ...
15
Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane Tazobactam in Pseudomonas aeruginosa
... toward ceftolozane and ...using ceftolozane-tazobactam, the evolution of the E221K (E247K including the signal peptide sequence) emerged in a Pseudomonas strain ...
19
<p>First Study of Antimicrobial Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against <em>Pseudomonas aeruginosa</em> Isolated from Patients with Urinary Tract Infection in Tehran, Iran</p>
... Ceftazidime-avibactam and ceftolozane-tazobactam showed high in vitro activity against a collection of P. aeruginosa isolated from patients with UTI in 2 Iranian hospitals. Thus, these agents could be ...
9
Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)
... for ceftolozane/ tazobactam plus metronidazole were sourced from pub- lished literature [35]; those same inputs for the second- line treatment of colistin + tigecycline + high-dose mer- openem were based on ...
15
Performance of Ceftolozane Tazobactam Etest, MIC Test Strips, and Disk Diffusion Compared to Reference Broth Microdilution for β Lactam Resistant Pseudomonas aeruginosa Isolates
... the ceftolozane-tazobactam (C-T) Etest (bioMérieux, Marcy l’Etoile, France), MIC test strips (MTS; Liofilchem, Italy), and disk diffusion (Hardy, Santa Ana, CA) were evaluated for a collection of 308 beta- ...
7
Verification of Ceftazidime Avibactam and Ceftolozane Tazobactam Susceptibility Testing Methods against Carbapenem Resistant Enterobacteriaceae and Pseudomonas aeruginosa
... and ceftolozane-tazobactam are newly approved agents for the treatment of infections caused by multidrug-resistant Gram-negative bac- ...and ceftolozane-tazobactam against a diverse collection ...
7
New Agent Ceftolozane/Tazobactam for the Treatment of Superbug - Pseudomonas aeruginosa Restoring the Miracle
... P. aeruginosa showed less resistance to ceftolozane as compared to other beta lactams. C/T showed a significant stability against class AmpC beta-lactamase. The synergistic effect with tazobactum makes it more ...
7
PubMedCentral-PMC4808171.pdf
... and tazobactam also found that dose fractionating the administration of both agents while maintaining the same drug exposure did not alter the killing of a TEM-producing strain of ...of ...
7
Critical evaluation of ceftolozane–tazobactam for complicated urinary tract and intra-abdominal infections
... receive ceftolozane–tazobactam plus metronidazole (n = 487) or mero- penem (n = 506), 806 ...with ceftolozane–tazobactam plus metronidazole and ...the ceftolozane–tazobactam plus ...
11
PubMedCentral-PMC5075062.pdf
... Study design and participants. This study was a prospective, multi- center, open-label pharmacokinetic trial (ClinicalTrials registration no. NCT02421120) of ceftolozane-tazobactam in 20 CF adults ...
7
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
... Materials and methods: Escherichia coli (n=686) and Klebsiella pneumoniae bloodstream isolates (n=673), non-typhoid Salmonella (NTS; n=221) from various sources, Shigella species (n=21) from fecal samples, and Neisseria ...
10
Multicenter Evaluation of the New Etest Gradient Diffusion Method for Piperacillin Tazobactam Susceptibility Testing of Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex
... piperacillin/ tazobactam for Escherichia coli and Klebsiella pneumoniae blood- stream infections that are non-susceptible to ceftriaxone from pa- tients enrolled in the MERINO trial, abstr ...for ...
9
Molecular detection of SHV-Type ESBL in E. coli and K.pneumoniae and their antimicrobial resistance profile
... acid, sulbactam, or tazobactam. 2,5 Production of ESBL enzymes is an Background and objective: The increase in the incidence of Beta-lactam resistance in Gram-negative bacteria has become a main clinical problem ...
11